Home › Insulin Resistance › California
Pag-aaral pangklinika para sa Insulin Resistance sa California
11 pag-aaral para sa Insulin Resistance ang naghahanap ng mga kalahok sa mga site sa California.
Mga Lungsod sa California
Opisyal na teksto ng pag-aaral (English)
Gauging Outcomes of Total Milk Ingestion on Lipid and gControl
- UCSF Medical Center at Parnassus, San Francisco
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07087184Type 1 Diabetes Extension Study
- UCSF School of Medicine, San Francisco
- Stanford University, Stanford
Nagre-recruitObservasyonal na pag-aaral
Edad 8 hanggang 35 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT02734277INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
- Children's Hospital Los Angeles, Los Angeles
- University of California San Francisco, San Francisco
Nagre-recruitPhase 2
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Ago 13, 2026 · NCT07224321DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
- Cedars Sinai Medical Center, Los Angeles
- University of California San Francisco, San Francisco
Nagre-recruitPhase 4
Edad 18 pataas · Kababaihan · Na-update Hun 25, 2026 · NCT06445946Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
- University of California Davis Health, Sacramento
Nagre-recruitPhase 2
Edad 21 hanggang 85 · Lahat ng kasarian · Na-update May 6, 2026 · NCT04984226A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500
- ProSciento, Inc., Chula Vista
Nagre-recruitPhase 1
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Abr 28, 2026 · NCT07341373Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
- Loma Linda University Cancer Center, Loma Linda
- Hoag Memorial Hospital Presbyterian, Newport
- SHARP Healthcare, San Diego
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 22, 2026 · NCT05455619Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
- Stanford University, Palo Alto
- Stanford University, Clinical and Translational Research Unit (CTRU), Stanford
Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo
Edad 30 hanggang 70 · Lahat ng kasarian · Na-update Abr 20, 2026 · NCT06657209Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance
- San Francisco Research Institute, San Francisco
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Ene 28, 2026 · NCT07220694Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2
- Stanford Health, Palo Alto
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Dis 4, 2024 · NCT05833217Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
- Stanford University, Stanford
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 35 hanggang 65 · Lahat ng kasarian · Na-update Dis 4, 2024 · NCT05165706Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.